blood redrawal
PreclinicalBiologic
blood redrawal is one of 107 biologic programs targeting Stroke. It is currently in Preclinical.
6
Indications
8
Total Trials
6
Active Trials
106
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
150 competitors in Stroke
#DrugCompanyPhaseTrials
1Aspirin or Clopidogrel
SSunnybrook Health Sciences Centre
Phase 3
Zometa
PfizerPreclinical
Savella
AbbViePreclinical
Proamatine
TakedaPreclinical
Repatha
AmgenPreclinical
Zantac 150
CChattem
Preclinical
Periactin
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Preclinical
Alka-Seltzer
AAbbott
Preclinical
Haldol
DDePuy Orthopaedics
Preclinical
Inderal
Mylan Pharmaceuticals IncPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
CRP Point-of-care Testing Trajectory1 trial
CRP Point-of-care Testing Trajectory, a Predictive Factor for Anastomotic Leak in Elective Colorectal Surgery
Recruiting·—·N/A·NCT07464600·500 enrolled
Stroke1 trial
Genetic Variants of Annexin A2 and Cryptogenic Stroke
Recruiting·—·N/A·NCT06880107·240 enrolled
Immune-related Adverse Events1 trial
Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment
Recruiting·—·N/A·NCT05813418·150 enrolled
Concentration1 trial
Self-estimates and Objective Blood Alcohol Concentration in Emergency Department
Completed·—·N/A·NCT03998397·34 enrolled
Antiphospholipid Syndrome1 trial
Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome
Recruiting·—·N/A·NCT06373926·60 enrolled
3 more indications
Binge Drinking1 trial
Smartphone Application for University Students With Binge Drinking Behavior
Recruiting·—·N/A·NCT06084832·628 enrolled
Testosterone1 trial
Comparison Between Calculated Bioavailable Testosterone Level With Radio-immunoassay Result.
Unknown status·—··NCT04807231·270 enrolled
Anemia1 trial
Genomic of CONgenital Sideroblastic Anemias
Recruiting·—·N/A·NCT07459816·20 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for blood redrawal. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details